Journal article

Long-term survival of elderly patients undergoing percutaneous coronary intervention for myocardial infarction complicated by cardiogenic shock

Han S Lim, Nick Andrianopoulos, Hariharan Sugumar, Dion Stub, Angela L Brennan, Chris CS Lim, Peter Barlis, William Van Gaal, Christopher M Reid, Kerrie Charter, Martin Sebastian, Gishel New, Andrew E Ajani, Omar Farouque, Stephen J Duffy, David J Clark



BACKGROUND: The long-term benefit of early percutaneous coronary intervention (PCI) for cardiogenic shock (CS) in elderly patients remains unclear. We sought to assess the long-term survival of elderly patients (age ≥ 75 years) with myocardial infarction (MI) complicated by CS undergoing PCI. METHODS: We analyzed baseline characteristics, early outcomes, and long-term survival in 421 consecutive patients presenting with MI and CS who underwent PCI from the Melbourne Interventional Group registry from 2004 to 2011. Mean follow-up of patients who survived to hospital discharge was 3.0 ± 1.8 years. RESULTS: Of the 421 consecutive patients, 122 patients were elderly (≥ 75 years) and 299 patients..

View full abstract


Funding Acknowledgements

The Melbourne Interventional Group acknowledges funding from Abbott, AstraZeneca, Biotronik, Boston Scientific, Bristol-Myers Squibb, Cordis Johnson & Johnson, CSL, Medtronic, MSD, Pfizer, Sanofi-Aventis, Servier, Schering-Plough and The Medicines Company. These companies do not have access to data and do not have the right to review manuscripts or abstracts before publication.Dr. Lim is supported by the Neil Hamilton Fairley Early Career Fellowship from the National Health and Medical Research Council (NHMRC) of Australia. Dr. Duffy's work is supported by a NHMRC Program Grant to the Alfred and Baker Medical Unit. Prof Reid's work is supported a NHMRC Senior Research Fellowship and NHMRC Program Grant.